Vivo Capital as of Sept. 30, 2018
Portfolio Holdings for Vivo Capital
Vivo Capital holds 44 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 15.5 | $154M | 2.2M | 70.86 | |
| Crinetics Pharmaceuticals In (CRNX) | 10.9 | $109M | 3.8M | 28.65 | |
| Biohaven Pharmaceutical Holding | 7.8 | $77M | 2.0M | 37.55 | |
| Codexis (CDXS) | 4.8 | $47M | 2.7M | 17.15 | |
| Sinovac Biotech (SVA) | 4.5 | $45M | 5.9M | 7.62 | |
| Arrowhead Pharmaceuticals (ARWR) | 4.5 | $45M | 2.3M | 19.17 | |
| Amyris | 4.5 | $44M | 5.6M | 7.94 | |
| Menlo Therapeutics | 4.0 | $40M | 4.0M | 9.85 | |
| Kadmon Hldgs | 3.5 | $35M | 11M | 3.34 | |
| Tricida | 3.0 | $30M | 992k | 30.55 | |
| Kalvista Pharmaceuticals (KALV) | 3.0 | $30M | 1.4M | 22.11 | |
| Homology Medicines | 2.7 | $27M | 1.2M | 22.86 | |
| Mei Pharma | 2.5 | $25M | 5.8M | 4.31 | |
| Apellis Pharmaceuticals (APLS) | 2.4 | $24M | 1.4M | 17.78 | |
| Aclaris Therapeutics (ACRS) | 2.4 | $24M | 1.6M | 14.52 | |
| Eiger Biopharmaceuticals | 2.2 | $22M | 1.8M | 12.00 | |
| Verona Pharma Plc ads (VRNA) | 1.9 | $19M | 1.5M | 12.51 | |
| Xenon Pharmaceuticals (XENE) | 1.9 | $19M | 1.4M | 13.20 | |
| Nabriva Therapeutics | 1.8 | $18M | 6.6M | 2.70 | |
| Acer Therapeutics | 1.8 | $17M | 566k | 30.84 | |
| Obseva Sa | 1.7 | $17M | 937k | 18.03 | |
| Selecta Biosciences | 1.2 | $12M | 761k | 15.55 | |
| Galmed Pharmaceuticals | 1.2 | $12M | 852k | 13.58 | |
| Kala Pharmaceuticals | 1.0 | $10M | 1.0M | 9.87 | |
| Cymabay Therapeutics | 1.0 | $10M | 906k | 11.08 | |
| Zymeworks | 1.0 | $9.7M | 620k | 15.70 | |
| Soleno Therapeutics | 0.9 | $9.4M | 4.4M | 2.16 | |
| Deciphera Pharmaceuticals | 0.8 | $8.2M | 213k | 38.72 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $8.1M | 1.2M | 6.64 | |
| Kiniksa Pharmaceuticals | 0.7 | $6.8M | 265k | 25.50 | |
| Genocea Biosciences | 0.6 | $6.4M | 8.2M | 0.78 | |
| Zogenix | 0.5 | $5.2M | 105k | 49.60 | |
| Arvinas Ord (ARVN) | 0.5 | $5.1M | 300k | 16.87 | |
| Strongbridge Bioph shs usd | 0.5 | $4.5M | 918k | 4.85 | |
| Zai Lab (ZLAB) | 0.5 | $4.5M | 231k | 19.48 | |
| Sierra Oncology | 0.4 | $4.1M | 2.4M | 1.70 | |
| Trevena | 0.4 | $3.7M | 1.7M | 2.12 | |
| Biopharmx | 0.3 | $3.1M | 16M | 0.19 | |
| Foamix Pharmaceuticals | 0.2 | $2.4M | 428k | 5.73 | |
| Akari Therapeutics | 0.1 | $885k | 346k | 2.56 | |
| Agile Therapeutics | 0.1 | $560k | 1.5M | 0.37 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $391k | 196k | 2.00 | |
| Gtx Inc Del | 0.0 | $165k | 105k | 1.57 | |
| Soleno Therapeutics, Inc. warrant | 0.0 | $23k | 189k | 0.12 |
